Zika vaccine shows promise in early human trial
October 04, 2017 at 17:00 PM EDT
CHICAGO, Oct 4 (Reuters) - A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.
